{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:34:42Z","timestamp":1715819682549},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.7759\/cureus.60334","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:22:24Z","timestamp":1715772144000},"source":"Crossref","is-referenced-by-count":0,"title":["Advanced Chronic Kidney Disease (CKD) in a Patient With Alstrom Syndrome"],"prefix":"10.7759","author":[{"given":"Moeed","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul  R","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana A","family":"Farman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree","volume":"129","author":"Alstrom CH","year":"1959","unstructured":"Alstrom CH, Hallgren B, Nilsson LB, Asander H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand Suppl. 1959, 129:1-35.","journal-title":"Acta Psychiatr Neurol Scand Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2021.01113","article-title":"A review of Alstr\u00f6m syndrome: a rare monogenic ciliopathy","volume":"10","author":"Choudhury AR","year":"2021","unstructured":"Choudhury AR, Munonye I, Sanu KP, Islam N, Gadaga C. A review of Alstr\u00f6m syndrome: a rare monogenic ciliopathy. Intractable Rare Dis Res. 2021, 10:257-62. 10.5582\/irdr.2021.01113","journal-title":"Intractable Rare Dis Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201933","article-title":"Alstr\u00f6m syndrome","volume":"15","author":"Marshall JD","year":"2007","unstructured":"Marshall JD, Beck S, Maffei P, Naggert JK. Alstr\u00f6m syndrome. Eur J Hum Genet. 2007, 15:1193-202. 10.1038\/sj.ejhg.5201933","journal-title":"Eur J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030008","article-title":"A role for Alstr\u00f6m syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence","volume":"3","author":"Li G","year":"2007","unstructured":"Li G, Vega R, Nelms K, et al.. A role for Alstr\u00f6m syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet. 2007, 3:e8. 10.1371\/journal.pgen.0030008","journal-title":"PLoS Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(96)70394-3","article-title":"Natural history of Alstr\u00f6m syndrome in early childhood: onset with dilated cardiomyopathy","volume":"128","author":"Michaud JL","year":"1996","unstructured":"Michaud JL, H\u00e9on E, Guilbert F, et al.. Natural history of Alstr\u00f6m syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr. 1996, 128:225-9. 10.1016\/s0022-3476(96)70394-3","journal-title":"J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01759.x","article-title":"Is arterial stiffening in Alstr\u00f6m syndrome linked to the development of cardiomyopathy?","volume":"37","author":"Smith JC","year":"2007","unstructured":"Smith JC, McDonnell B, Retallick C, et al.. Is arterial stiffening in Alstr\u00f6m syndrome linked to the development of cardiomyopathy?. Eur J Clin Invest. 2007, 37:99-105. 10.1111\/j.1365-2362.2007.01759.x","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.168","article-title":"Coronary artery disease in Alstr\u00f6m syndrome","volume":"20","author":"Jatti K","year":"2012","unstructured":"Jatti K, Paisey R, More R. Coronary artery disease in Alstr\u00f6m syndrome. Eur J Hum Genet. 2012, 20:117-8. 10.1038\/ejhg.2011.168","journal-title":"Eur J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1292","article-title":"Early-onset liver disease complicated with acute liver failure in Alstrom syndrome","volume":"101","author":"Quiros-Tejeira RE","year":"2001","unstructured":"Quiros-Tejeira RE, Vargas J, Ament ME. Early-onset liver disease complicated with acute liver failure in Alstrom syndrome. Am J Med Genet. 2001, 101:9-11. 10.1002\/ajmg.1292","journal-title":"Am J Med Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf8683","article-title":"Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity","volume":"373","author":"Akbari P","year":"2021","unstructured":"Akbari P, Gilani A, Sosina O, et al.. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science. 2021, 373:10.1126\/science.abf8683","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17374-3","article-title":"Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions","volume":"11","author":"Fahed AC","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, et al.. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020, 11:3635. 10.1038\/s41467-020-17374-3","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0315-6","article-title":"Treatment with PBI-4050 in patients with Alstr\u00f6m syndrome: study protocol for a phase 2, single-centre, single-arm, open-label trial","volume":"18","author":"Baig S","year":"2018","unstructured":"Baig S, Veeranna V, Bolton S, et al.. Treatment with PBI-4050 in patients with Alstr\u00f6m syndrome: study protocol for a phase 2, single-centre, single-arm, open-label trial. BMC Endocr Disord. 2018, 18:88. 10.1186\/s12902-018-0315-6","journal-title":"BMC Endocr Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/254539-advanced-chronic-kidney-disease-ckd-in-a-patient-with-alstrom-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:22:29Z","timestamp":1715772149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/254539-advanced-chronic-kidney-disease-ckd-in-a-patient-with-alstrom-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.60334","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}